Expertise in
5
conditions

Christoph Schliemann

Muenster, NW, DE 
Expertise in
5
conditions
Muenster, NW, DE 

Overview

Christoph Schliemann practices practicing medicine in Muenster, Germany.

Mr. Schliemann is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Necrosis, Adult Soft Tissue Sarcoma, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 158 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Muenster, NW, Germany
Other Locations
Essen, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase I Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With the Anti-CD33 Antibody BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation
A Phase I Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With the Anti-CD33 Antibody BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation
Enrollment Status: Completed
Publish Date: April 20, 2022
Intervention Type: Drug
Study Drugs: F16IL2, BI 836858
Study Phase: Phase 1
Phase I Study of the Tumor-targeting Human L19TNFα Monoclonal Antibody-cytokine Fusion Protein in Combination With Doxorubicin in Patients With Advanced Solid Tumours
Phase I Study of the Tumor-targeting Human L19TNFα Monoclonal Antibody-cytokine Fusion Protein in Combination With Doxorubicin in Patients With Advanced Solid Tumours
Enrollment Status: Completed
Publish Date: April 04, 2022
Intervention Type: Drug
Study Drugs: L19TNF?, Doxorubicin
Study Phase: Phase 1
Phase I Study of tTF-NGR in Patients With Recurrent or Refractory Malignant Tumors and Lymphomas Beyond All Standard Treatments
Phase I Study of tTF-NGR in Patients With Recurrent or Refractory Malignant Tumors and Lymphomas Beyond All Standard Treatments
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Biological
Study Phase: Phase 1
View 2 Less Clinical Trials

158 Total Publications

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.
Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.
Journal: Haematologica
Published: April 20, 2026

Frequently Asked Questions about Christoph Schliemann

Is Christoph Schliemann a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Christoph Schliemann is classified as an Elite expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christoph Schliemann participate in research or clinical trials?

Yes. Christoph Schliemann has published 158 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Christoph Schliemann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schliemann's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile